Spyre Therapeutics, Inc. (SYRE)

43.21 +5.40 (+14.28%) USD  |  NASDAQ  |  Feb 20, 16:00
43.80 +0.59 (+1.37%) After-Hours: 20:00
More

Spyre Therapeutics Other Properties (Quarterly)

Other Properties (Quarterly) Chart

View Other Properties (Quarterly) for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Properties (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Properties (Quarterly) Range, Past 5 Years

View Other Properties (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Properties (Quarterly) Benchmarks

View Other Properties (Quarterly) Benchmarks
Start Trial
PTC Therapeutics, Inc. Upgrade
Tandem Diabetes Care, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. --